Glenmark Pharmaceuticals Ltd. India
Quick facts
Marketed products
- Diclofenac Sodium gel, 1% · Pain Management / Rheumatology
Diclofenac sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of application. - Voltaren® Gel · Pain Management / Rheumatology
Voltaren Gel is a topical nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce local inflammation and pain at the site of application.
Phase 3 pipeline
- DYMISTA nasal spray · Allergy/Immunology
DYMISTA is a nasal spray combining azelastine (a selective H1-receptor antagonist) and fluticasone propionate (a corticosteroid) to reduce allergic rhinitis symptoms through dual anti-inflammatory and antihistamine action. - Elidel® (pimecrolimus) Cream · Dermatology/Immunology
Pimecrolimus is a calcineurin inhibitor that suppresses T-cell activation and inflammatory cytokine production in the skin. - Placebo of Pimecrolimus Cream, 1% · Dermatology
This is a placebo formulation with no active pharmacological mechanism. - Placebo of Tacrolimus Ointment · Immunology
Tacrolimus ointment is an immunosuppressant that works by inhibiting calcineurin, a protein necessary for T-cell activation. - Protopic® ointment, 0.1% · Dermatology
Protopic ointment, 0.1% works by inhibiting the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) to reduce inflammation.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: